4//SEC Filing
Prothena Corp plc 4
Accession 0000899243-15-004426
$PRTACIK 0001559053operating
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:06 PM ET
Size
17.4 KB
Accession
0000899243-15-004426
Insider Transaction Report
Form 4
Koller Martin
Chief Medical Officer
Transactions
- Exercise/Conversion
Ordinary Shares, par value $0.01 per share
2015-09-01$6.73/sh+24,600$165,558→ 24,600 total - Sale
Ordinary Shares, par value $0.01 per share
2015-09-01$56.18/sh−2,950$165,717→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2015-09-01−24,600→ 100,400 totalExercise: $6.73Exp: 2023-03-31→ Ordinary Shares (24,600 underlying) - Sale
Ordinary Shares, par value $0.01 per share
2015-09-02$55.17/sh−5,400$297,919→ 0 total - Exercise/Conversion
Ordinary Shares, par value $0.01 per share
2015-09-02$6.73/sh+5,400$36,342→ 5,400 total - Exercise/Conversion
Stock Option (right to buy)
2015-09-02−5,400→ 95,000 totalExercise: $6.73Exp: 2023-03-31→ Ordinary Shares (5,400 underlying) - Sale
Ordinary Shares, par value $0.01 per share
2015-09-01$55.58/sh−21,650$1,203,279→ 2,950 total
Footnotes (5)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $55.00 to $55.98, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The transaction was executed in multiple trades in prices ranging from $56.00 to $56.53, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F4]The transaction was executed in multiple trades in prices ranging from $55.00 to $55.46, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F5]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 25, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Prothena Corp plc
CIK 0001559053
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001559053
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 4:06 PM ET
- Size
- 17.4 KB